_id
690f3b06ccc777a4e85d1994
Ticker
CAMRF
Name
Camurus AB (publ)
Exchange
OTCGREY
Address
Ideon Science Park, Lund, Sweden, 223 70
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.camurus.com
Description
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain; and Brixadi to treat opioid use disorder. It also provides CAM2038 for the treatment of chronic pain; CAM2029, which completed phase III clinical trials for the treatment of acromegaly, and phase III clinical trials to treat gastroenteropancreatic neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM2056 that is in phase I clinical trials for the treatment of metabolic diseases; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity; and Gubra A/S to develop long-acting therapeutic option for the treatment of hypoparathyroidism; as well as NewBridge Pharmaceuticals. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden.
Last Close
67.125
Volume
155
Current Price
67.125
Change
-2.575
Last Updated
2026-01-02T10:53:08.965Z
Image
data:image/webp;base64,UklGRlYGAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSMsEAAABGTVtG7A4HWci+h/mciYgIsIhRrJt2lrXeLZt5p/Ht20829znnggiJmACqG3/f7bZl/QNamzpbOvRddu27Ue27ftd2LZtW/N21W5TY0tTJB2bf5qImAAEtpK4koqsuDAvOxuLvrouCKVC1Of3uePQrNPK0sLSytIKrJj1VaEkiMVYIBjwhssbWtDEpGWYFlp+tPUMjEzN6Bi5VqtKlbV8IZfhQ34f3zRRQkhciArYyvmF33+dzdaaYiprUvR96gHmab/fNbcQqgDUhjoOQQUpc2Bx/ttP/nRBZV1CScy7DrA8Mv/P33NxgNogS4pJsAMunb+/96UMcpusOIcPwGfN9/1X/0UAakNZVpLDCnDr++utT+pQropLcPsD/MrB999xFpTFRTmtANe/ff7NP4oMVSmvAGBFwE9u6bV3sgpUQQluAAAC4Fh68SlXsVFB3hdg29dSlsAYLRytAv748JvZRk0p35hMdLT0FSrQ29sHe/UqJBZeeGM3QYydBOgjty59GzK5iBJYg9XRPTY+2gJsUEoQe+LJ9C4hfjNA7/n27FnbAhxkuIOOPWY/GqTPPeFa20mJ+UKa+nTuSUCUAI7tmjro0P2HSH586+eVnawQ2qc3T9qAPHjApeewBLPff/ITABh8HFYoLReeJQHDwfMumuaUCJHZP36ZBQAvjQCIXd9e9ADTQ089+aBGctGzODvviQP4uPUA9cqdMGDr2HPNpTvW+DifiPNxPpkvAQR5/CGdeObECPY777ShXvQuLa04w1Xs7uXURXk3sgLML77Ylk9GeT6eSEpo6GbXR/jXogL2++6h0h5fBcodTEOEH20uFrS3bQjpCghNhjHCrw4PC9Q1aRYIHX12nGlUQOwbMXCmkFDGplSciUhzcxLOHnrURPDcY3vXtPXgQwaC55/yrGvr/vtMBC+/6C1q66477ARvv+XNauvmG9oIPv/MHdPWVZd3Msp++3XFra1LLuqzKXM6//tXPb3RossIJKefOtKtLJv88Wv17K0thkJEJDj8sJkJZSh/9Zl6vaMOO2cs8PFEotJoemb/Awnw1TeSaiNDFj3XJmay6SwvNuDajz6Z5J9QvahSS7sdgLXb0e7gjHk+kcoUARjOvpSkiNiiOrYuVgIAU09XT5dVzKQTsfSOyy6kCCB7sh1qMPtMeNGYsvRylnogAABnH6+jCVDQURkypme8Q1YAGHtNG+nkjgPGHb0kFUgd+3YqMwzNdPtrICxk7NjZbpk5hAQGbnrYxChhh7qGbBsgdaX6dgF71FF1EoBB3/EXXHqaUAVjsLY6ypkgiEuJvGk3HHEATRPBus+Zl5x7UlnaYPRGzlQBeS0p1tFwqtXYTwbAbOsz6iDXxCLU9Pu70ZgujR6gCph2i46C2kvRQQVg9nTnVWlmxSvSrBK0y8ZBbfliRiinqR5LSktJb6qHAHVzFR3aSSayEogN0JfCWomtxsYAUBvKUBETVU4b0WS0BAAbIGXA8H+H5KallvnqCFSW0wtuoU43SXSG1mioLxmyf//wZ0K9YjAQsfZb0UzZ+dMPrnVpQyUhwofzJjRdqgW/ffv1L/5cCabWqywNuVaVKuuFfC4rWDt7GWiw8P/Hb33+195wWpDA0huyVK3tyGdEFuQAVlA4IGQBAABwCQCdASpAAEAAPrFMmkm/v6IhMfVck/AWCWYAt+wTjYD7RCQE7bLnjNM73n6jt1tUcwIv6qqKvETSW0Ol+k6vOHP6IB01cC9KK2SRYC1xhpDLBgAA/uob//pB//WVf/9Ruk2MPM5ej+YLPh0REqEcCGouyTcEJCOf3grXazrN0Dilj4zGQ+gFkosfi775uhKs2pFapIft838FJtQEe+ZcRv/KO6JEsyYGiIDHnO2Pq2hGPpd7cpDt5NNKRd5uMwX4XhvqCQBA5LfJsYj2tPm9ZOUoBY08Lmobl9WcqfSTn47+62UqPrMDuVUMxHAEZ4NVm8vmN3i85LpzCEp5XK1x8mpYK/DSOGolnCvI0elnrv+kSSc4ZUOCJyCGLtuyhP1SALdDBuHGj6R6CD5dhQ9KU63zVcON+/q08ElwSpLxBlaj1Y1x1V64iAJMo+h5vAZGMUOHF+7yau1N7kY3nJMw9aBgAA==
Ipo Date
-
Market Cap
4057580032
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
675501000
Cost Of Revenue
41137000
Gross Profit
634364000
Operating Expenses
383451000
Operating Income
292050000
Interest Expense
1418000
Pretax Income
307010000
Net Income
244791000
Eps
4.119633021445901
Dividends Per Share
-
Shares Outstanding
59632834
Income Tax Expense
-
EBITDA
-
Operating Margin
43.23457700284678
Total Other Income Expense Net
-
Cash
3347420000
Short Term Investments
-
Receivables
511169000
Inventories
123814000
Total Current Assets
4176749000
Property Plant Equipment
204307000
Total Assets
4424060000
Payables
80570000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
553524000
Equity
3870536000
Bs_currency_symbol
SEK
Depreciation
6284000
Change In Working Capital
26792000
Cash From Operations
375782000
Capital Expenditures
27409000
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
470314000
Cf_currency_symbol
SEK
PE
47.2711
PB
1.0305050000826759
ROE
6.324472889542947
ROA
5.53317540901344
FCF
348373000
Fcf Percent
0.5157253653214429
Piotroski FScore
4
Health Score
80
Deep Value Investing Score
8
Defensive Investing Score
7.5
Dividend Investing Score
3
Economic Moat Investing Score
9
Garp Investing Score
6.5
Growth Investing Score
6
Momentum Investing Score
4
Net Net Investing Score
6
Quality Investing Score
8.5
Value Investing Score
8
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
675501000
Quarters > 0 > income Statement > cost Of Revenue
41137000
Quarters > 0 > income Statement > gross Profit
634364000
Quarters > 0 > income Statement > operating Expenses
383451000
Quarters > 0 > income Statement > operating Income
292050000
Quarters > 0 > income Statement > interest Expense
1418000
Quarters > 0 > income Statement > pretax Income
307010000
Quarters > 0 > income Statement > net Income
244791000
Quarters > 0 > income Statement > eps
4.119633021445901
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
59420584
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
43.23457700284678
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
SEK
Quarters > 0 > balance Sheet > cash
3347420000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
511169000
Quarters > 0 > balance Sheet > inventories
123814000
Quarters > 0 > balance Sheet > total Current Assets
4176749000
Quarters > 0 > balance Sheet > property Plant Equipment
204307000
Quarters > 0 > balance Sheet > total Assets
4424060000
Quarters > 0 > balance Sheet > payables
80570000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
553524000
Quarters > 0 > balance Sheet > equity
3870536000
Quarters > 0 > balance Sheet > currency_symbol
SEK
Quarters > 0 > cash Flow > net Income
244791000
Quarters > 0 > cash Flow > depreciation
6284000
Quarters > 0 > cash Flow > change In Working Capital
26792000
Quarters > 0 > cash Flow > cash From Operations
375782000
Quarters > 0 > cash Flow > capital Expenditures
27409000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
470314000
Quarters > 0 > cash Flow > currency_symbol
SEK
Quarters > 0 > ratios > PE
4.119633021445901
Quarters > 0 > ratios > PB
1.0305050000826759
Quarters > 0 > ratios > ROE
6.324472889542947
Quarters > 0 > ratios > ROA
5.53317540901344
Quarters > 0 > ratios > FCF
348373000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.5157253653214429
Quarters > 0 > health Score
80
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
558342000
Quarters > 1 > income Statement > cost Of Revenue
39292000
Quarters > 1 > income Statement > gross Profit
519050000
Quarters > 1 > income Statement > operating Expenses
319460000
Quarters > 1 > income Statement > operating Income
238882000
Quarters > 1 > income Statement > interest Expense
1335000
Quarters > 1 > income Statement > pretax Income
253959000
Quarters > 1 > income Statement > net Income
197253000
Quarters > 1 > income Statement > eps
3.363852375563315
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
58639018
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
42.78417170837945
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
SEK
Quarters > 1 > balance Sheet > cash
2878054000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
508825000
Quarters > 1 > balance Sheet > inventories
134257000
Quarters > 1 > balance Sheet > total Current Assets
3677603000
Quarters > 1 > balance Sheet > property Plant Equipment
182059000
Quarters > 1 > balance Sheet > total Assets
3969128000
Quarters > 1 > balance Sheet > payables
65187000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
482149000
Quarters > 1 > balance Sheet > equity
3486979000
Quarters > 1 > balance Sheet > currency_symbol
SEK
Quarters > 1 > cash Flow > net Income
197253000
Quarters > 1 > cash Flow > depreciation
5643000
Quarters > 1 > cash Flow > change In Working Capital
-168022000
Quarters > 1 > cash Flow > cash From Operations
77635000
Quarters > 1 > cash Flow > capital Expenditures
34144000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
37395000
Quarters > 1 > cash Flow > currency_symbol
SEK
Quarters > 1 > ratios > PE
3.363852375563315
Quarters > 1 > ratios > PB
1.1288120987393386
Quarters > 1 > ratios > ROE
5.656845079938823
Quarters > 1 > ratios > ROA
4.969680997942117
Quarters > 1 > ratios > FCF
43491000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.07789311927098445
Quarters > 1 > health Score
65
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
553131000
Quarters > 2 > income Statement > cost Of Revenue
33321000
Quarters > 2 > income Statement > gross Profit
519810000
Quarters > 2 > income Statement > operating Expenses
387064000
Quarters > 2 > income Statement > operating Income
166067000
Quarters > 2 > income Statement > interest Expense
284000
Quarters > 2 > income Statement > pretax Income
186244000
Quarters > 2 > income Statement > net Income
146981000
Quarters > 2 > income Statement > eps
2.5065392466156236
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
58639018
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
30.023086755217122
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
SEK
Quarters > 2 > balance Sheet > cash
2852699000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
416344000
Quarters > 2 > balance Sheet > inventories
140223000
Quarters > 2 > balance Sheet > total Current Assets
3549116000
Quarters > 2 > balance Sheet > property Plant Equipment
57737000
Quarters > 2 > balance Sheet > total Assets
3757012000
Quarters > 2 > balance Sheet > payables
118253000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
467331000
Quarters > 2 > balance Sheet > equity
3289681000
Quarters > 2 > balance Sheet > currency_symbol
SEK
Quarters > 2 > cash Flow > net Income
146981000
Quarters > 2 > cash Flow > depreciation
3514000
Quarters > 2 > cash Flow > change In Working Capital
-62993000
Quarters > 2 > cash Flow > cash From Operations
103250000
Quarters > 2 > cash Flow > capital Expenditures
19887000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
98796000
Quarters > 2 > cash Flow > currency_symbol
SEK
Quarters > 2 > ratios > PE
2.5065392466156236
Quarters > 2 > ratios > PB
1.196512392310987
Quarters > 2 > ratios > ROE
4.467940812498234
Quarters > 2 > ratios > ROA
3.9121780819438428
Quarters > 2 > ratios > FCF
83363000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.15071113352894702
Quarters > 2 > health Score
71
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
479597000
Quarters > 3 > income Statement > cost Of Revenue
33513000
Quarters > 3 > income Statement > gross Profit
446084000
Quarters > 3 > income Statement > operating Expenses
337769000
Quarters > 3 > income Statement > operating Income
141828000
Quarters > 3 > income Statement > interest Expense
235000
Quarters > 3 > income Statement > pretax Income
165312000
Quarters > 3 > income Statement > net Income
129349000
Quarters > 3 > income Statement > eps
2.208497880645193
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
58568768
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
29.572328434081115
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
SEK
Quarters > 3 > balance Sheet > cash
2751262000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
321858000
Quarters > 3 > balance Sheet > inventories
146918000
Quarters > 3 > balance Sheet > total Current Assets
3335410000
Quarters > 3 > balance Sheet > property Plant Equipment
40168000
Quarters > 3 > balance Sheet > total Assets
3566475000
Quarters > 3 > balance Sheet > payables
78401000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
454195000
Quarters > 3 > balance Sheet > equity
3112280000
Quarters > 3 > balance Sheet > currency_symbol
SEK
Quarters > 3 > cash Flow > net Income
129349000
Quarters > 3 > cash Flow > depreciation
3695000
Quarters > 3 > cash Flow > change In Working Capital
16138000
Quarters > 3 > cash Flow > cash From Operations
149663000
Quarters > 3 > cash Flow > capital Expenditures
5929000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
186224000
Quarters > 3 > cash Flow > currency_symbol
SEK
Quarters > 3 > ratios > PE
2.208497880645193
Quarters > 3 > ratios > PB
1.2631988612849743
Quarters > 3 > ratios > ROE
4.156084928091302
Quarters > 3 > ratios > ROA
3.626802374893978
Quarters > 3 > ratios > FCF
143734000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2996974543210237
Quarters > 3 > health Score
76
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1867581000
Annuals > 0 > income Statement > cost Of Revenue
129507000
Annuals > 0 > income Statement > gross Profit
1738074000
Annuals > 0 > income Statement > operating Expenses
1403951000
Annuals > 0 > income Statement > operating Income
463630000
Annuals > 0 > income Statement > interest Expense
999000
Annuals > 0 > income Statement > pretax Income
552522000
Annuals > 0 > income Statement > net Income
428394000
Annuals > 0 > income Statement > eps
7.2758346615087905
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
58879018
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
24.825161532485073
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
SEK
Annuals > 0 > balance Sheet > cash
2852699000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
416344000
Annuals > 0 > balance Sheet > inventories
140223000
Annuals > 0 > balance Sheet > total Current Assets
3549116000
Annuals > 0 > balance Sheet > property Plant Equipment
57737000
Annuals > 0 > balance Sheet > total Assets
3757012000
Annuals > 0 > balance Sheet > payables
118253000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
467331000
Annuals > 0 > balance Sheet > equity
3289681000
Annuals > 0 > balance Sheet > currency_symbol
SEK
Annuals > 0 > cash Flow > net Income
428394000
Annuals > 0 > cash Flow > depreciation
14637000
Annuals > 0 > cash Flow > change In Working Capital
-205092000
Annuals > 0 > cash Flow > cash From Operations
387990000
Annuals > 0 > cash Flow > capital Expenditures
29371000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
1659287000
Annuals > 0 > cash Flow > currency_symbol
SEK
Annuals > 0 > ratios > PE
7.2758346615087905
Annuals > 0 > ratios > PB
1.20140952367418
Annuals > 0 > ratios > ROE
13.02235687898006
Annuals > 0 > ratios > ROA
11.40251881016084
Annuals > 0 > ratios > FCF
358619000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.19202326431892378
Annuals > 0 > health Score
87
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1716850000
Annuals > 1 > income Statement > cost Of Revenue
122348000
Annuals > 1 > income Statement > gross Profit
1594502000
Annuals > 1 > income Statement > operating Expenses
1183440000
Annuals > 1 > income Statement > operating Income
533410000
Annuals > 1 > income Statement > interest Expense
1275000
Annuals > 1 > income Statement > pretax Income
549304000
Annuals > 1 > income Statement > net Income
431442000
Annuals > 1 > income Statement > eps
7.7564533828058435
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
55623618
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
31.06910912426828
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
SEK
Annuals > 1 > balance Sheet > cash
1189840000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
274071000
Annuals > 1 > balance Sheet > inventories
100955000
Annuals > 1 > balance Sheet > total Current Assets
1624069000
Annuals > 1 > balance Sheet > property Plant Equipment
39682000
Annuals > 1 > balance Sheet > total Assets
1907820000
Annuals > 1 > balance Sheet > payables
99278000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
414819000
Annuals > 1 > balance Sheet > equity
1493001000
Annuals > 1 > balance Sheet > currency_symbol
SEK
Annuals > 1 > cash Flow > net Income
431442000
Annuals > 1 > cash Flow > depreciation
13987000
Annuals > 1 > cash Flow > change In Working Capital
-44446000
Annuals > 1 > cash Flow > cash From Operations
606878000
Annuals > 1 > cash Flow > capital Expenditures
10127000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
625514000
Annuals > 1 > cash Flow > currency_symbol
SEK
Annuals > 1 > ratios > PE
7.7564533828058435
Annuals > 1 > ratios > PB
2.50082575848911
Annuals > 1 > ratios > ROE
28.897636371308526
Annuals > 1 > ratios > ROA
22.6143975846778
Annuals > 1 > ratios > FCF
596751000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.3475848210385299
Annuals > 1 > health Score
94
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
956340000
Annuals > 2 > income Statement > cost Of Revenue
103265000
Annuals > 2 > income Statement > gross Profit
853075000
Annuals > 2 > income Statement > operating Expenses
885076000
Annuals > 2 > income Statement > operating Income
71264000
Annuals > 2 > income Statement > interest Expense
1212000
Annuals > 2 > income Statement > pretax Income
73125000
Annuals > 2 > income Statement > net Income
55553000
Annuals > 2 > income Statement > eps
1.0023448189230606
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
55423043
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
7.451743103917018
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
SEK
Annuals > 2 > balance Sheet > cash
565539000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
196863000
Annuals > 2 > balance Sheet > inventories
107431000
Annuals > 2 > balance Sheet > total Current Assets
915345000
Annuals > 2 > balance Sheet > property Plant Equipment
34880000
Annuals > 2 > balance Sheet > total Assets
1305488000
Annuals > 2 > balance Sheet > payables
85548000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
310817000
Annuals > 2 > balance Sheet > equity
994671000
Annuals > 2 > balance Sheet > currency_symbol
SEK
Annuals > 2 > cash Flow > net Income
55553000
Annuals > 2 > cash Flow > depreciation
12936000
Annuals > 2 > cash Flow > change In Working Capital
-17639000
Annuals > 2 > cash Flow > cash From Operations
101199000
Annuals > 2 > cash Flow > capital Expenditures
1905000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
150286000
Annuals > 2 > cash Flow > currency_symbol
SEK
Annuals > 2 > ratios > PE
1.0023448189230606
Annuals > 2 > ratios > PB
3.7402033047862058
Annuals > 2 > ratios > ROE
5.585062799659385
Annuals > 2 > ratios > ROA
4.255343595651588
Annuals > 2 > ratios > FCF
99294000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.10382709078361252
Annuals > 2 > health Score
62
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
600570000
Annuals > 3 > income Statement > cost Of Revenue
85352000
Annuals > 3 > income Statement > gross Profit
515218000
Annuals > 3 > income Statement > operating Expenses
712927000
Annuals > 3 > income Statement > operating Income
-112357000
Annuals > 3 > income Statement > interest Expense
1365000
Annuals > 3 > income Statement > pretax Income
-111768000
Annuals > 3 > income Statement > net Income
-90446000
Annuals > 3 > income Statement > eps
-1.6496140042573413
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
54828584
Annuals > 3 > income Statement > income Tax Expense
-21322000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-18.70839369265864
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
411575000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
135994000
Annuals > 3 > balance Sheet > inventories
107202000
Annuals > 3 > balance Sheet > total Current Assets
679302000
Annuals > 3 > balance Sheet > property Plant Equipment
34728000
Annuals > 3 > balance Sheet > total Assets
1081897000
Annuals > 3 > balance Sheet > payables
52857000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
232989000
Annuals > 3 > balance Sheet > equity
848908000
Annuals > 3 > balance Sheet > currency_symbol
SEK
Annuals > 3 > cash Flow > net Income
-90446000
Annuals > 3 > cash Flow > depreciation
8845000
Annuals > 3 > cash Flow > change In Working Capital
-53323000
Annuals > 3 > cash Flow > cash From Operations
-143427000
Annuals > 3 > cash Flow > capital Expenditures
3991000
Annuals > 3 > cash Flow > cash From Investing
-4943000
Annuals > 3 > cash Flow > cash From Financing
98904000
Annuals > 3 > cash Flow > net Change In Cash
-50218000
Annuals > 3 > cash Flow > currency_symbol
SEK
Annuals > 3 > ratios > PE
-1.6496140042573413
Annuals > 3 > ratios > PB
4.335415264080442
Annuals > 3 > ratios > ROE
-10.654393644540987
Annuals > 3 > ratios > ROA
-8.359945540102247
Annuals > 3 > ratios > FCF
-147418000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.24546347636412075
Annuals > 3 > health Score
29
Valuation > metrics > PE
47.2711
Valuation > metrics > PB
1.0305050000826759
Valuation > final Score
53.274680000000004
Valuation > verdict
44.5% Overvalued
Profitability > metrics > ROE
6.324472889542947
Profitability > metrics > ROA
5.8608022651109755
Profitability > metrics > Net Margin
0.3623843636056793
Profitability > final Score
60
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.1430096503430016
Risk > metrics > Interest Coverage
205.95909732016926
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
51.840002482313515
Liquidity > metrics > Quick Ratio
50.30327665384138
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
57
Prev Profitabilities > 1
51
Prev Profitabilities > 2
50
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:33:13.352Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
3.28
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-12-31
Earnings History > 1 > report Date
2023-02-13
Earnings History > 1 > date
2022-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0.23
Earnings History > 1 > eps Estimate
0.29
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-20.6897
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-11-09
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.63
Earnings History > 2 > eps Estimate
0.14
Earnings History > 2 > eps Difference
0.49
Earnings History > 2 > surprise Percent
350
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-07-14
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.14
Earnings History > 3 > eps Estimate
-0.24
Earnings History > 3 > eps Difference
0.38
Earnings History > 3 > surprise Percent
158.3333
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-05-11
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
-0.26
Earnings History > 4 > eps Difference
0.25
Earnings History > 4 > surprise Percent
96.1538
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-02-15
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.26
Earnings History > 5 > eps Estimate
-0.32
Earnings History > 5 > eps Difference
0.06
Earnings History > 5 > surprise Percent
18.75
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-11-03
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-07-14
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.89
Earnings History > 7 > eps Estimate
-0.52
Earnings History > 7 > eps Difference
-0.37
Earnings History > 7 > surprise Percent
-71.1538
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-05-06
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.97
Earnings History > 8 > eps Difference
0.57
Earnings History > 8 > surprise Percent
58.7629
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2021-02-10
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.22
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-09-30
Earnings History > 10 > report Date
2020-11-04
Earnings History > 10 > date
2020-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.38
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.38
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-07-15
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0424
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0424
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-03-31
Earnings History > 12 > report Date
2020-05-07
Earnings History > 12 > date
2020-03-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0418
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0418
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-12-31
Earnings History > 13 > report Date
2020-02-11
Earnings History > 13 > date
2019-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.47
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-09-30
Earnings History > 14 > report Date
2019-11-07
Earnings History > 14 > date
2019-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.31
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-06-30
Earnings History > 15 > report Date
2019-07-17
Earnings History > 15 > date
2019-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.83
Earnings History > 15 > eps Estimate
-1.93
Earnings History > 15 > eps Difference
0.1
Earnings History > 15 > surprise Percent
5.1813
Earnings History > 16 > period
2019-03-31
Earnings History > 16 > report Date
2019-05-09
Earnings History > 16 > date
2019-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.5
Earnings History > 16 > eps Estimate
-1.74
Earnings History > 16 > eps Difference
0.24
Earnings History > 16 > surprise Percent
13.7931
Earnings History > 17 > period
2018-12-31
Earnings History > 17 > report Date
2019-02-05
Earnings History > 17 > date
2018-12-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-2.08
Earnings History > 17 > eps Estimate
-3.02
Earnings History > 17 > eps Difference
0.94
Earnings History > 17 > surprise Percent
31.1258
Earnings History > 18 > period
2018-09-30
Earnings History > 18 > report Date
2018-10-24
Earnings History > 18 > date
2018-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.04
Earnings History > 18 > eps Estimate
-1.56
Earnings History > 18 > eps Difference
0.52
Earnings History > 18 > surprise Percent
33.3333
Earnings History > 19 > period
2018-06-30
Earnings History > 19 > report Date
2018-07-16
Earnings History > 19 > date
2018-06-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.66
Earnings History > 19 > eps Estimate
-1.01
Earnings History > 19 > eps Difference
-0.65
Earnings History > 19 > surprise Percent
-64.3564
Earnings History > 20 > period
2018-03-31
Earnings History > 20 > report Date
2018-05-03
Earnings History > 20 > date
2018-03-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.89
Earnings History > 20 > eps Estimate
-1.1
Earnings History > 20 > eps Difference
0.21
Earnings History > 20 > surprise Percent
19.0909
Earnings History > 21 > period
2017-12-31
Earnings History > 21 > report Date
2018-02-14
Earnings History > 21 > date
2017-12-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.28
Earnings History > 21 > eps Estimate
-2.01
Earnings History > 21 > eps Difference
0.73
Earnings History > 21 > surprise Percent
36.3184
Earnings History > 22 > period
2017-09-30
Earnings History > 22 > report Date
2017-10-25
Earnings History > 22 > date
2017-09-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.28
Earnings History > 22 > eps Estimate
-0.73
Earnings History > 22 > eps Difference
-0.55
Earnings History > 22 > surprise Percent
-75.3425
Earnings History > 23 > period
2017-06-30
Earnings History > 23 > report Date
2017-07-12
Earnings History > 23 > date
2017-06-30
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.1723
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.1723
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2017-03-31
Earnings History > 24 > report Date
2017-05-03
Earnings History > 24 > date
2017-03-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.146
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.146
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2016-12-31
Earnings History > 25 > report Date
2017-02-15
Earnings History > 25 > date
2016-12-31
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.1205
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.1205
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2016-09-30
Earnings History > 26 > report Date
2016-11-07
Earnings History > 26 > date
2016-09-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0819
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0819
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2016-06-30
Earnings History > 27 > report Date
2016-07-13
Earnings History > 27 > date
2016-06-30
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0413
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0413
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2016-03-31
Earnings History > 28 > report Date
2016-05-16
Earnings History > 28 > date
2016-03-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.065
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.065
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2015-12-31
Earnings History > 29 > report Date
2016-02-16
Earnings History > 29 > date
2015-12-31
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0643
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0643
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2015-09-30
Earnings History > 30 > report Date
2015-11-17
Earnings History > 30 > date
2015-09-30
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.1244
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.1244
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2015-06-30
Earnings History > 31 > report Date
2015-09-30
Earnings History > 31 > date
2015-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.1075
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.1075
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2015-03-31
Earnings History > 32 > report Date
2015-06-30
Earnings History > 32 > date
2015-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.5503
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.5503
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2014-12-31
Earnings History > 33 > report Date
2015-03-31
Earnings History > 33 > date
2014-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
0.047
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
0.047
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2014-09-30
Earnings History > 34 > report Date
2014-12-31
Earnings History > 34 > date
2014-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
0.3109
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
0.3109
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2014-06-30
Earnings History > 35 > report Date
2014-09-30
Earnings History > 35 > date
2014-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.0374
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-0.0374
Earnings History > 35 > surprise Percent
-
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain; and Brixadi to treat opioid use disorder. It also provides CAM2038 for the treatment of chronic pain; CAM2029, which completed phase III clinical trials for the treatment of acromegaly, and phase III clinical trials to treat gastroenteropancreatic neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM2056 that is in phase I clinical trials for the treatment of metabolic diseases; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity; and Gubra A/S to develop long-acting therapeutic option for the treatment of hypoparathyroidism; as well as NewBridge Pharmaceuticals. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACamurus: Why It Has Become A Meaningful Position In Our Portfolio (CAMRF) Seeking Alpha
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Medium
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Camurus AB (publ)
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
3.28
Date
2022-12-31
EPS Actual
0.23
EPS Estimate
0.29
EPS Difference
-0.06
Surprise Percent
-20.6897%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.